Effect of diabetes therapy on the myocardium in experimental diabetes
- PMID: 113974
- DOI: 10.1007/BF02581092
Effect of diabetes therapy on the myocardium in experimental diabetes
Abstract
The effects of chronic antidiabetic treatment were examined in a clinically manifest, but non-ketotic diabetic animal model in which increased stabilization of steric structure in the cardiac connective tissue and left ventricular diastolic stiffness have been demonstrated. These changes accounted for decreased left ventricular performance during left ventricular afterload. Each of 8 diabetic dogs was given daily 8-16 IU of insulin, 250-750 mg carbutamide or 2-10 mg glibenclamide, respectively; doses were always adjusted to the actual metabolic requirements and findings were compared to those of 11 untreated diabetic and 6 healthy dogs. After three months, the hemodynamic and metabolic studies showed that the metabolically controlled diabetic dogs had less marked alterations in the connective cardiac tissue, left ventricular diastolic stiffness and performance. Apart from a considerable rise of arterial blood pressure during carbutamide treatment, no other difference was found in the cardiac actions of the three hypoglycemic agents tested.
Similar articles
-
Haemodynamic and metabolic effects of low daily dose sulphonylureas in diabetic dog hearts.Arzneimittelforschung. 2002;52(7):552-9. doi: 10.1055/s-0031-1299929. Arzneimittelforschung. 2002. PMID: 12189779
-
[The effect of the treatment of diabetes mellitus on the development of cardiac changes in alloxan diabetes].Orv Hetil. 1980 Jan 13;121(2):91-4. Orv Hetil. 1980. PMID: 6768045 Hungarian. No abstract available.
-
The effects of tolbutamide on the myocardium in experimental diabetes.Circulation. 1977 Jan;55(1):200-5. doi: 10.1161/01.cir.55.1.200. Circulation. 1977. PMID: 830209
-
[The action of blood glucose lowering sulfonamides on liver metabolism].Acta Diabetol Lat. 1969 Sep;6 Suppl 1:396-414. Acta Diabetol Lat. 1969. PMID: 4906022 Review. Multiple languages. No abstract available.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
Cited by
-
Altered adrenergic responses of the coronary arterial bed in alloxan-diabetic dogs.Experientia. 1982 Aug 15;38(8):934-5. doi: 10.1007/BF01953661. Experientia. 1982. PMID: 7128730 No abstract available.
-
Effect of acute hypoxia on cardiac function in alloxan-diabetic dogs.Basic Res Cardiol. 1986 Jan-Feb;81(1):92-100. doi: 10.1007/BF01907431. Basic Res Cardiol. 1986. PMID: 3718428
-
The heart in diabetes.West J Med. 1984 Apr;140(4):583-93. West J Med. 1984. PMID: 6372249 Free PMC article. Review.
-
Evaluation of cardiac functions with tissue Doppler imaging in prediabetic subjects.Korean Circ J. 2013 Feb;43(2):82-6. doi: 10.4070/kcj.2013.43.2.82. Epub 2013 Feb 28. Korean Circ J. 2013. PMID: 23508684 Free PMC article.
-
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.Heart Fail Rev. 2012 May;17(3):325-44. doi: 10.1007/s10741-011-9257-z. Heart Fail Rev. 2012. PMID: 21626163 Review.